Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

Phillips 66

Phillips 66 Raises $50B in Public

2331 CityWest Boulevard, Houston, TX 77042January 1, 20242 min read
Employees
13000+

Phillips 66 Raises $50B in Public


Phillips 66 has successfully raised $50B in a Public at a $55B valuation led by Public.


Company Overview


Phillips 66 is a Energy company headquartered in 2331 CityWest Boulevard, Houston, TX 77042, founded in 2012 with 13000+ employees.


Energy manufacturing and logistics


Fundraising Details


  • Amount Raised: $50B
  • Round Type: Public
  • Valuation: $55B
  • Date: 2024-01-01
  • Investors: Public

About Phillips 66


Energy manufacturing and logistics The company is positioned in the Energy sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 2331 CityWest Boulevard, Houston, TX 77042
  • Founded: 2012
  • Team Size: 13000+
  • Industry: Energy

What This Means


This funding round demonstrates strong investor confidence in Phillips 66's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Energy sector continues to attract significant investment as companies innovate to meet evolving market demands. Phillips 66's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $55B valuation marks an important milestone for Phillips 66, positioning the company among notable players in the Energy industry.


Looking Ahead


With this new capital, Phillips 66 is well-positioned to execute on its growth strategy and continue building innovative solutions in the Energy space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Phillips 66, visit their headquarters at 2331 CityWest Boulevard, Houston, TX 77042.

Company Info

Headquarters
2331 CityWest Boulevard, Houston, TX 77042
Founded
2012
Team Size
13000+

Topics

Fundraising(2912)Public(771)EnergyPhillips 66

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free